Medline Industries Plans IPO as Soon as This Year, FT Reports

Medline Industries, backed by Blackstone, Hellman & Friedman and Carlyle, confidentially refiled its draft prospectus for an initial public offering with the US Securities and Exchange Commission last week, the Financial Times reported, citing three people familiar with the matter.

The listing could raise between $4 billion and $5 billion, and value the medical supply group at more than $50 billion, according to the newspaper.

Medline’s board is set to meet next week to make a final decision about whether to IPO in the remaining months of 2025 or pursue the offering early 2026. The group’s owners have not ...